Literature DB >> 20888781

Influence of geriatric consultation with comprehensive geriatric assessment on final therapeutic decision in elderly cancer patients.

Pascal Chaïbi1, Nicolas Magné, Sylvie Breton, Amale Chebib, Sarah Watson, Jean-Jacques Duron, Laurent Hannoun, Jean-Pierre Lefranc, François Piette, Fabrice Menegaux, Jean-Philippe Spano.   

Abstract

Elderly patients represent a heterogeneous population in which decisions on cancer treatment are often difficult. The present study aims to report a 2-year period of the activity of geriatric assessment consultations and the impact on treatment decisions. Since January 2007, we have systematically carried out geriatric consultations, using well-known international scales, for elderly patients in whom treatment decisions appear complex to oncologists. From January 2007 to November 2008, 161 patients (57 men, 104 women; median age 82.4 years, range 73-97) were seen at geriatric consultations. Most of the patients (134/161) were undergoing first-line treatment and cancer was metastatic in 86 patients (53%). Geriatric assessment found severe comorbidities (grade 3 or 4 in CIRS-G scale) in 75 patients, dependence for at least one activity of daily living (ADL) in 52 patients, cognitive impairment in 42 patients, malnutrition in 104 patients (65%) and depression in 39 patients. According to the oncologists' prior decisions, there were no changes in treatment decisions in only 29 patients. Cancer treatment was changed in 79 patients (49%), including delayed therapy in 5 patients, less intensive therapy in 29 patients and more intensive therapy in 45 patients. Patients for whom the final decision was delayed or who underwent less intensive therapy had significantly more frequent severe comorbidities (23/34, p<0.01) and dependence for at least one ADL (19/34, p<0.01). In this study, we have found that comprehensive geriatric evaluation did significantly influence treatment decisions in 82% of our older cancer patients.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20888781     DOI: 10.1016/j.critrevonc.2010.08.004

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  41 in total

1.  Cancer-specific geriatric assessment and quality of life: important factors in caring for older patients with aggressive B-cell lymphoma.

Authors:  Karin Ribi; Stéphanie Rondeau; Felicitas Hitz; Ulrich Mey; Milica Enoiu; Thomas Pabst; Anastasios Stathis; Natalie Fischer; Kerri M Clough-Gorr
Journal:  Support Care Cancer       Date:  2017-04-13       Impact factor: 3.603

2.  Influence of the geriatric oncology consultation on the final therapeutic decision in elderly subjects with cancer: analysis of 191 patients.

Authors:  M Blanc; O Dialla; P Manckoundia; P Arveux; S Dabakuyo; V Quipourt
Journal:  J Nutr Health Aging       Date:  2014-01       Impact factor: 4.075

Review 3.  Squamous cell carcinoma of the head and neck in the elderly.

Authors:  Jasenka Gugić; Primož Strojan
Journal:  Rep Pract Oncol Radiother       Date:  2012-08-10

4.  Geriatric Assessment-Guided Care Processes for Older Adults: A Delphi Consensus of Geriatric Oncology Experts.

Authors:  Supriya Gupta Mohile; Carla Velarde; Arti Hurria; Allison Magnuson; Lisa Lowenstein; Chintan Pandya; Anita O'Donovan; Rita Gorawara-Bhat; William Dale
Journal:  J Natl Compr Canc Netw       Date:  2015-09       Impact factor: 11.908

Review 5.  Arti Hurria and the progress in integrating the geriatric assessment into oncology: Young International Society of Geriatric Oncology review paper.

Authors:  Clark DuMontier; Mina S Sedrak; Wee Kheng Soo; Cindy Kenis; Grant R Williams; Kristen Haase; Magnus Harneshaug; Hira Mian; Kah Poh Loh; Siri Rostoft; William Dale; Harvey Jay Cohen
Journal:  J Geriatr Oncol       Date:  2019-08-23       Impact factor: 3.599

6.  Using Big Data in oncology to prospectively impact clinical patient care: A proof of concept study.

Authors:  Vérène Dougoud-Chauvin; Jae Jin Lee; Edgardo Santos; Vonetta L Williams; Nicolò M L Battisti; Kavita Ghia; Marina Sehovic; Cortlin Croft; Jongphil Kim; Lodovico Balducci; Julie A Kish; Martine Extermann
Journal:  J Geriatr Oncol       Date:  2018-04-17       Impact factor: 3.599

7.  Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology.

Authors:  Supriya G Mohile; William Dale; Mark R Somerfield; Mara A Schonberg; Cynthia M Boyd; Peggy S Burhenn; Beverly Canin; Harvey Jay Cohen; Holly M Holmes; Judith O Hopkins; Michelle C Janelsins; Alok A Khorana; Heidi D Klepin; Stuart M Lichtman; Karen M Mustian; William P Tew; Arti Hurria
Journal:  J Clin Oncol       Date:  2018-05-21       Impact factor: 44.544

Review 8.  Management of locally advanced rectal cancer in the elderly: a critical review and algorithm.

Authors:  Lara Hathout; Nell Maloney-Patel; Usha Malhotra; Shang-Jui Wang; Sita Chokhavatia; Ishita Dalal; Elizabeth Poplin; Salma K Jabbour
Journal:  J Gastrointest Oncol       Date:  2018-04

Review 9.  Long-term Toxicity of Cancer Treatment in Older Patients.

Authors:  Armin Shahrokni; Abraham J Wu; Jeanne Carter; Stuart M Lichtman
Journal:  Clin Geriatr Med       Date:  2015-10-13       Impact factor: 3.076

10.  Doublet chemotherapy in the elderly patient with ovarian cancer.

Authors:  Min Y Teo; Derek G Power; William P Tew; Stuart M Lichtman
Journal:  Oncologist       Date:  2012-08-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.